CRIP1 and sarcoma: After performing log-rank tests in the TCGA SARC cohort and validating these good-prognosis-related genes with the GEO dataset GSE17679, we extracted information indicating that NR1H3, VAMP5, GIMAP2, GBP2, HLA-E and CRIP1 were highly expressed in the immune microenvironment and were most significantly associated with predicting good outcomes in sarcoma patients (Figure 3D–3I, Supplementary Figure 2).